210 related articles for article (PubMed ID: 34636430)
21. (11) C and (18) F PET radioligands for the serotonin transporter (SERT).
Stehouwer JS; Goodman MM
J Labelled Comp Radiopharm; 2013; 56(3-4):114-9. PubMed ID: 24285317
[TBL] [Abstract][Full Text] [Related]
22. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Kretz J; Gobbi L; Ahmed H; Atz K; Bürkler M; Bartelmus C; Fingerle J; Guba W; Ullmer C; Honer M; Knuesel I; Weber M; Brink A; Herde AM; Keller C; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2019 Dec; 62(24):11165-11181. PubMed ID: 31751140
[TBL] [Abstract][Full Text] [Related]
23. Development of a kit-like radiofluorinated biomolecule leading to a controlled self-assembly of
Lin J; Wang W; Li K; Huang H; Lv G; Peng Y; Luo S; Qiu L
Chem Commun (Camb); 2017 Jun; 53(48):6476-6479. PubMed ID: 28569906
[TBL] [Abstract][Full Text] [Related]
24.
Gao F; Zhang Y; Chen M; Song Z; Dong R; Qiu S; Shen C; Huang X; Geng H; Cheng W; Hu J
Eur J Pharm Sci; 2024 Feb; 193():106671. PubMed ID: 38104907
[TBL] [Abstract][Full Text] [Related]
25. Radiosynthesis of (S)-[
Sarasamkan J; Fischer S; Deuther-Conrad W; Ludwig FA; Scheunemann M; Arunrungvichian K; Vajragupta O; Brust P
Appl Radiat Isot; 2017 Jun; 124():106-113. PubMed ID: 28365525
[TBL] [Abstract][Full Text] [Related]
26. A general chemical method to regulate protein stability in the mammalian central nervous system.
Iwamoto M; Björklund T; Lundberg C; Kirik D; Wandless TJ
Chem Biol; 2010 Sep; 17(9):981-8. PubMed ID: 20851347
[TBL] [Abstract][Full Text] [Related]
27. Current status of positron emission tomography radiotracers for serotonin receptors in humans.
Zimmer L; Le Bars D
J Labelled Comp Radiopharm; 2013; 56(3-4):105-13. PubMed ID: 24285316
[TBL] [Abstract][Full Text] [Related]
28.
Hu F; Morris PJ; Bonaventura J; Fan H; Mathews WB; Holt DP; Lam S; Boehm M; Dannals RF; Pomper MG; Michaelides M; Horti AG
Eur J Med Chem; 2021 Mar; 213():113047. PubMed ID: 33280897
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Brain Dysfunction Induced by Bacterial Lipopeptides That Alter Neuronal Activity and Network in Rodent Brains.
Kim KM; Zamaleeva AI; Lee YW; Ahmed MR; Kim E; Lee HR; Pothineni VR; Tao J; Rhee S; Jayakumar M; Inayathullah M; Sivanesan S; Red-Horse K; Palmer TD; Park J; Madison DV; Lee HY; Rajadas J
J Neurosci; 2018 Dec; 38(50):10672-10691. PubMed ID: 30381406
[TBL] [Abstract][Full Text] [Related]
30. Mesoporous silica nanoparticle pretargeting for PET imaging based on a rapid bioorthogonal reaction in a living body.
Lee SB; Kim HL; Jeong HJ; Lim ST; Sohn MH; Kim DW
Angew Chem Int Ed Engl; 2013 Sep; 52(40):10549-52. PubMed ID: 23956036
[TBL] [Abstract][Full Text] [Related]
31. Advances in [
Francis F; Wuest F
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770885
[TBL] [Abstract][Full Text] [Related]
32. (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain.
Shrestha SS; Liow JS; Lu S; Jenko K; Gladding RL; Svenningsson P; Morse CL; Zoghbi SS; Pike VW; Innis RB
J Nucl Med; 2014 Jan; 55(1):141-6. PubMed ID: 24385311
[TBL] [Abstract][Full Text] [Related]
33. (R)-[
Berroterán-Infante N; Kalina T; Fetty L; Janisch V; Velasco R; Vraka C; Hacker M; Haug AR; Pallitsch K; Wadsak W; Mitterhauser M
Eur J Med Chem; 2019 Aug; 176():410-418. PubMed ID: 31125895
[TBL] [Abstract][Full Text] [Related]
34. 18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase.
Horti AG; Wang Y; Minn I; Lan X; Wang J; Koehler RC; Alkayed NJ; Dannals RF; Pomper MG
J Nucl Med; 2016 Nov; 57(11):1817-1822. PubMed ID: 27417650
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699.
Caillé F; Morley TJ; Tavares AA; Papin C; Twardy NM; Alagille D; Lee HS; Baldwin RM; Seibyl JP; Barret O; Tamagnan GD
Bioorg Med Chem Lett; 2013 Dec; 23(23):6243-7. PubMed ID: 24157369
[TBL] [Abstract][Full Text] [Related]
36. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
37. In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging.
Verdurand M; Levigoureux E; Zeinyeh W; Berthier L; Mendjel-Herda M; Cadarossanesaib F; Bouillot C; Iecker T; Terreux R; Lancelot S; Chauveau F; Billard T; Zimmer L
Mol Pharm; 2018 Aug; 15(8):3153-3166. PubMed ID: 29989823
[TBL] [Abstract][Full Text] [Related]
38. Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type-1 receptors.
Ahamed M; Verbruggen A; Bormans G
J Labelled Comp Radiopharm; 2013; 56(3-4):207-14. PubMed ID: 24285327
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and preliminary biological evaluation of radiolabeled 5-BDBD analogs as new candidate PET radioligands for P2X4 receptor.
Wang M; Gao M; Meyer JA; Peters JS; Zarrinmayeh H; Territo PR; Hutchins GD; Zheng QH
Bioorg Med Chem; 2017 Jul; 25(14):3835-3844. PubMed ID: 28554730
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the Efficacy and Sensitivity of Alternative PET Reporter Gene/PET Reporter Probe Systems That Minimize Biological Variables.
Xu S; Herschman HR
Methods Mol Biol; 2020; 2126():177-190. PubMed ID: 32112389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
